However, he said that many countries, especially the European Union, are likely to step up production and increase their portfolios in an attempt to reduce import reliability.
For Q3 as a whole, it sees outbound shipment declining by 1.77%
Exports fell sharper at 8.7% in November from 5.1% in October, as demand remained muted in major overseas markets due to Covid-induced lockdowns
Covid-induced lockdowns in advanced nations hit exports, trade deficit at nine-month high
The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic nature of prescription drugs, investment information agency ICRA has said.
Among manufactured goods, only drugs & pharmaceuticals and plastic and linoleum have shown positive growth
The country ranks as the third-largest pharma market globally by volume and 13 largest by value
Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April
Firm says will apply to Indian pharma authorities to start studies
Pharma industry welcomes decision, but wants govt to consider allowing export of APIs made before March 3
India's list of restricted medicines account for 10 per cent of its total pharmaceutical exports and includes several antibiotics, as well as Paracetamol
India on Monday reported two new cases of the novel coronavirus, including one from the national capital. The outbreak has killed more than 3,000 people globally
April-December exports rise 11.5%; estimates peg FY20 numbers at $22 billion
Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports
The US is Indian pharma's largest export market and Indian drugmakers account for a little over 30 per cent of generic drugs sold in that country
Indian pharma exports registered a double-digit growth of 10.17 per cent at $16.89 billion last time in 2015-16
BS ReporterHyderabad, 3 August: State drug controllers have been given complete jurisdiction to issue no objection certificates(NOCs) for manufacture of unapproved, banned or new drugs that are solely meant for exports. The Drug Control General of India (DCGI) discontinued the earlier practice wherein the grant of such NoCs were being overseen by the Central Drugs Standard Control Organisation(CDSCO). These orders will come into effect from August 20, 2018.The Pharmaceutical Export Promotion Council of India (Pharmexcil) has recently approached the drug regulator seeking a waiver of bio equivalence(BE) studies for grant of license of oral dosage form of drugs specified under BCS category 2 and 4 for export purpose.Drug controllers in some states were insisting on submission of results of BE studies endorsed by the CDSO for grant of license to manufacture such drugs for export purpose and this has been causing difficulties to the exporters, according to Pharmexcil. "In order to ...
In April, pharma exports to the US has grown by 17.47 per cent as compared to a 10 per cent decline in the same month last year
Currently, pharma shipments make up only 0.3% of the total $13.33 billion exports to China
Pharma exports now seem to be losing their importance due to poor growth